loading

Vir Biotechnology Inc Azioni (VIR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
824.05K%
238.95
-0.029 64.07 0.24 1.214
Cost Of Revenue
-
- - - 0.011
Selling, General, and Administrative
29.38%
30.20
23.34 - - -
Costs And Expenses
25.12%
165.48
132.26 111.99 173.68 119.63
Operating Income/Loss
155.53%
73.47
-132.29 -47.92 -173.44 -118.42
Nonoperating Income/Loss
0.40%
6.792
6.765 4.861 10.47 7.629
Income/Loss From Continuing Operations Before Tax
163.94%
80.26
-125.53 -43.06 -162.97 -110.79
Income Tax Expense/Benefit
5.29%
0.179
0.17 -0.137 0.168 0.17
Net Income/Loss
163.71%
80.08
-125.69 -42.92 -163.14 -110.96
Basic Average Shares
13.82%
167.72
147.36 0.2329 138.93 138.45
Diluted Average Shares
14.61%
168.88
147.36 0.2329 138.93 138.45
Basic Earnings Per Share
156.47%
0.48
-0.85 -0.30 -1.17 -0.80
Diluted Earnings Per Share
155.29%
0.47
-0.85 -0.30 -1.17 -0.80
$21.82
price down icon 0.23%
$18.13
price up icon 1.80%
$18.89
price up icon 5.06%
$132.91
price up icon 5.29%
$45.38
price up icon 4.37%
$13.35
price up icon 6.71%
Capitalizzazione:     |  Volume (24 ore):